SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-21-000024
Filing Date
2021-08-04
Accepted
2021-08-04 06:04:54
Documents
76
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20210630.htm   iXBRL 10-Q 2144390
2 EX-31.1 uthrex31106302021.htm EX-31.1 11814
3 EX-31.2 uthrex31206302021.htm EX-31.2 11811
4 EX-32.1 uthrex32106302021.htm EX-32.1 6631
5 EX-32.2 uthrex32206302021.htm EX-32.2 6749
  Complete submission text file 0001082554-21-000024.txt   8843781

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20210630.xsd EX-101.SCH 53703
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20210630_cal.xml EX-101.CAL 69365
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20210630_def.xml EX-101.DEF 296065
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20210630_lab.xml EX-101.LAB 684918
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20210630_pre.xml EX-101.PRE 439120
11 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20210630_htm.xml XML 1662435
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 211142192
SIC: 2834 Pharmaceutical Preparations